Contact this trialFirst, we need to learn more about you.
Oral ABBV-552 for Alzheimer's Disease
Recruiting0 awardsPhase 2
Marrero, Louisiana
This trial tests a new drug called ABBV-552 to see if it can help people aged 50-90 with early Alzheimer's disease. Participants will take the drug daily for a few months, and researchers will check its effects on memory and other symptoms.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.